Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone.
about
Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectivesUse of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in KoreaManagement of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors.Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.Management of the adverse effects of lenalidomide in multiple myeloma.The clinical safety of lenalidomide in multiple myeloma and myelodysplastic syndromes.Lenalidomide for the treatment of relapsed and refractory multiple myeloma.Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based studyDexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesisLenalidomide in multiple myeloma-a practice guideline.Thrombosis is associated with inferior survival in multiple myeloma.Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipientsMultiple Myeloma, Version 2.2016: Clinical Practice Guidelines in OncologyOptimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement.Lenalidomide: a review of its use in the treatment of relapsed or refractory multiple myeloma.Thrombosis in multiple myeloma (MM).Multiple Myeloma: Cast Nephropathy, VTE, and Neurologic Complications.Current treatment landscape for relapsed and/or refractory multiple myeloma.Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell originA review of the venous thrombotic issues associated with multiple myeloma.Absence of tissue factor expression by neoplastic plasma cells in multiple myeloma.Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens.Monoclonal gammopathy of undetermined significance and risk of venous thromboembolismAnticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms
P2860
Q26799104-5B9485FF-0AAF-4DA4-95A3-374CC947E427Q26992002-06547B39-62B1-4F4A-A30B-BBD38F729E52Q30417015-D527FA88-42FA-4749-BE51-FFD8AE9DAE92Q30595175-B8389E9C-3262-4211-85F5-EA25427B4A41Q33394632-AD85ABED-DCAF-4003-BA0D-6C406400396BQ33398044-98E1E3FF-EF57-409F-B3BD-0A74B8D833A6Q33403183-47D686F7-D65B-4BDD-B6A3-016C5CA57991Q33931754-386D0C89-30FF-45D0-A20D-E5153E42349FQ34411693-5585FF14-0E6B-4311-B711-213F07B2DC48Q34656086-97D459C2-B283-4D5F-AFDD-1D83159D9D3CQ36366986-C0E3796A-5932-4FC3-B668-B0A15A068D0BQ36862372-7FA4A769-ADAC-42AB-AAE1-A9735A4E2D13Q36963203-3E360851-8851-4C40-9746-4BDCB6E1A533Q37835695-9A46FD00-D3A3-4A43-ABE4-CC4489FA7B3CQ37858523-1E858B82-71C3-46A7-A742-3A821EC05A1FQ38003019-D2E2558C-B4AC-45DF-9459-5E40DDAD0FA2Q38230423-AFDFDC01-A7F0-48EA-BBDB-ECCDFFEE9DAAQ38271032-F50A9937-6279-4EF1-85EA-5B35F95E8B36Q38496748-B7E42CAD-B126-46EE-BE02-AFAAE0137A68Q38845946-4C5D05FC-B331-4348-B47F-183805704F27Q39396683-29B7C717-7090-4124-8CCA-20DA21234412Q50916755-1AF9B10D-2A6D-4665-A85C-B39B54C5AEFDQ57300330-393E6D89-EE4B-4E4E-BCF6-6A581B2BBED3Q58554222-72FE7F5C-745C-4385-AEFB-4B215E1CFC28
P2860
Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Survival effect of venous thro ...... e and high-dose dexamethasone.
@en
Survival effect of venous thro ...... e and high-dose dexamethasone.
@nl
type
label
Survival effect of venous thro ...... e and high-dose dexamethasone.
@en
Survival effect of venous thro ...... e and high-dose dexamethasone.
@nl
prefLabel
Survival effect of venous thro ...... e and high-dose dexamethasone.
@en
Survival effect of venous thro ...... e and high-dose dexamethasone.
@nl
P2093
P50
P356
P1476
Survival effect of venous thro ...... e and high-dose dexamethasone.
@en
P2093
Ashlie Finlayson
Donna Weber
Guido Tricot
Latha Polavaram
Louis Fink
Robert Knight
P304
P356
10.1200/JCO.2009.23.0169
P407
P577
2009-11-09T00:00:00Z